The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
PF-06952229 ID: ALA5095192
Cas Number: 1801333-55-0
PubChem CID: 118211239
Product Number: P649080, Order Now?
Max Phase: Phase
Molecular Formula: C23H24ClFN4O3
Molecular Weight: 458.92
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Synonyms: Pf 06952229 | Pf-06952229 | PF06952229 | PF-06952229|1801333-55-0|PF06952229|1KKS7U3X86|UNII-1KKS7U3X86|PF-06952229 [WHO-DD]|3-Pyridinecarboxamide, 4-((2-(5-chloro-2-fluorophenyl)-5-(1-methylethyl)-4-pyridinyl)amino)-N-(2-hydroxy-1-(hydroxymethyl)ethyl)-|Synthesis of 4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyridyl]amino]-N-[2-hydroxy-1-(hydroxymethyl)ethyl]pyridine-3-carboxamide|4-[[2-(5-chloro-2-fluorophenyl)-5-propan-2-ylpyridin-4-yl]amino]-N-(1,3-dihydroxypropan-2-yl)pyridine-3-carboxa Show More⌵
Canonical SMILES: CC(C)c1cnc(-c2cc(Cl)ccc2F)cc1Nc1ccncc1C(=O)NC(CO)CO
Standard InChI: InChI=1S/C23H24ClFN4O3/c1-13(2)17-10-27-21(16-7-14(24)3-4-19(16)25)8-22(17)29-20-5-6-26-9-18(20)23(32)28-15(11-30)12-31/h3-10,13,15,30-31H,11-12H2,1-2H3,(H,28,32)(H,26,27,29)
Standard InChI Key: IPBLCOKXDQHSQW-UHFFFAOYSA-N
Molfile:
Untitled Document-1
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
16.8666 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1522 -5.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4377 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7232 -5.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7232 -5.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4377 -6.2576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1522 -5.8451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8666 -3.7826 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.5811 -5.0201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.0101 -5.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2956 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2956 -3.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0101 -3.3701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.7245 -4.6076 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.4377 -3.7826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2943 -3.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0088 -3.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7232 -3.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7232 -2.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0088 -2.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2943 -2.5451 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4377 -2.1326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1522 -2.5726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4652 -1.2251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5798 -3.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8653 -3.3701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1509 -3.7826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1509 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8653 -5.0201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5798 -4.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8653 -2.5451 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.8653 -5.8451 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
10 11 1 0
11 12 1 0
12 13 1 0
10 14 1 0
9 11 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
22 23 1 0
22 24 1 0
19 22 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
26 31 1 0
29 32 1 0
16 25 1 0
15 18 1 0
3 15 1 0
M END
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: YesAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 458.92Molecular Weight (Monoisotopic): 458.1521AlogP: 3.89#Rotatable Bonds: 8Polar Surface Area: 107.37Molecular Species: NEUTRALHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.91CX Basic pKa: 6.90CX LogP: 4.06CX LogD: 3.94Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.41Np Likeness Score: -0.92
References 1. Unpublished dataset, 2. Abdel-Magid AF.. (2022) Inhibitors of Transforming Growth Factor Beta Receptor 1 (TGFβr1) May Enhance the Efficacy of Several Monoclonal Antibodies as Cancer Therapy., 13 (9.0): [PMID:36105341 ] [10.1021/acsmedchemlett.2c00356 ] 3. Pujala B, Ramachandran SA, Sonawane M, Kamble MM, Panpatil D, Adhikari S, Soni S, Subbareddy V, Shinde BU, Nayak AK, Bansal C, Gupta A, Mukherjee K, Agarwal AK, Guerrero J, Herrera FJ, Bernales S, Guha M, Chakravarty S, Pham SM, Rai R.. (2022) Discovery of MDV6058 (PF-06952229), a selective and potent TGFβR1 inhibitor: Design, synthesis and optimization., 75 [PMID:36089110 ] [10.1016/j.bmcl.2022.128979 ]